INTRODUCTION
The mucosa of the digestive tract is rich in endocrine cells, which have been classified into enterochromaffin and enterochromaffin-like cells. They can be collectively demonstrated by so-called argyrophil staining techniques. The enterochromaffin cells contain serotonin or catecholamines, which accounts for the fact that they can be stained with chromaffin or argentaffin staining techniques. The enterochromaffin-like cells do not contain serotonin or catecholamines and cannot be stained with chromaffin or argentaffin staining techniques. Like the enterochromaffin cells, they have the capacity to convert DOPA or 5-HTP to dopamine and serotonin, respectively, and to store the amine in the secretory granules for some time. The term enterochromaffln-like derives from the fact that after these cells have been induced to store monoamines they are structurally and histochemically indistinguishable from the enterochromaffin cells [1] . The oxyntic mucosa of the rat stomach is rich in enterochromaffln-like cells [1] . They comprise several distinct cell types: ECL cells, A-like acteristics of the different cell types [2, 3] . The ECL cells have an irregular, slender shape, sometimes with quite long extensions, and the cytoplasm contains numerous, quite large electron-lucent vesicles and a few, small electron-dense granules [4, 5] .
Due to their content of histamine and of the histamine-forming enzyme histidine decarboxylase (HDC), the ECL cells can be demonstrated by immunocytochemistry using antibodies to histamine [6] or to the HDC [7] . In addition, the ECL cells are known to display immunoreactivity for chromogranin A-derived peptides such as pancreastatin [6, [8] [9] [10] [11] . Of the various endocrine cells (enterochromaffin and enterochromaffin-like cells) in the oxyntic mucosa, only the ECL cells produce histamine [6, 7, 12, 13] and respond to gastrin by the release of histamine [11, [14] [15] [16] , which mediates the gastrininduced stimulation of acid secretion from the parietal cells [17, 18] . The ECL cells respond to gastrin according to a precise time-table [19, 20] . Among acute effects (manifested within minutes) are the release of histamine and pancreastatin [11] . Among less immediate effects (within hours) are those manifested first in the activation of HDC and subsequently in the increased expression of HDC mRNA [11] . Long-term effects of hypergastrinemia include hypertrophy (after several days of hypergastrinemia), hyperplasia (after weeks of hypergastrinemia), and dysplasia/neoplasia (after one to two years) [21, 22] .
HISTAMINE, PANCREASTATIN AND EXOCYTOTIC PROTEINS IN ECL CELLS

Light microscopy
The ECL cells are numerous in the oxyntic mucosa of rat, mouse and hamster, while mast cells are comparatively few. In these species, histamine immunostaining provides an excellent method for the demonstration of ECL cells. In mammals, the ECL cells are restricted to the oxyntic mucosa and occur in the basal half of the mucosa (Figure 1 ). Double immunostaining with antibodies against HDC and vesicular monoamine transporter type 2 (VMAT-2) revealed the presence of VMAT-2 immunoreactivity in the ECL cells ( Figure 2 ). The protein-protein interactions behind the intracellular transport of cytoplasmic organelles and behind the process of exocytosis has been extensively studied in neurons. The ECL cells were found to display immunoreactivity for synaptophysin (Figure 3 ), synaptotagmin III, vesicle-associated membrane protein-2 (VAMP-2), cysteine string protein (CSP), synaptosomal-associated protein of 25 kDa (SNAP-25), syntaxin and Munc-18, but not for synaptotagmin I/II and VAMP-1 [23] . These findings suggest that the proteins that promote or participate in the docking and fusion of granules/vesicles to the plasma membrane are similar in neurons and ECL cells.
.
Confocal mleroscopy
The precise subcellular localization of ECL cell histamine remains unknown. The failure to demonstrate histamine at the subcellular level, e.g., by immunoelectron microscopy, may reflect the diffusion of histamine from its storage site because of inadequate fixation or because of the destruction of the antibody-recognizing epitopes by the fixation. By confocal microscopy of immunostained section we were able to show that histamine is present ? s i _ : # . j E 9 w :
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both in the cytosol and in the secretory vesicles but usually at a much higher concentration in the latter site. HDC immunoreactivity was found to occur in the cytosol only ( Figure 4 ).
Electron microscopy ECL cells have been identified as the only endocrine cell type in rat oxyntic mucosa that contains histamine by electron microscopic immunocytochemistry for histamine [12] . The ECL cells contain not only histamine but also pancreastatin. In fact, the ECL cells are the main source of circulating pancreastatin in the rat [24] [25] [26] . Pancreastatin is derived from chromogranin A. Chromogranin/pancreastatin is probably synthesized, packaged, stored, processed and secreted in parallel with the anticipated ECL cell-peptide hormone. The gastrin-induced release of pancreastatin parallels that of histamine, while pancreastatin can be released independently of histamine, for instance, after blocking histamine synthesis [27] . At the electron microscopic level, we could show that ECL cell-pancreastatin occurs in the dense cores of the granules/vesicles ( Figure 5 ). We suggest that the electron dense parts of the organelles are the storage site for pancreastatin and other secretory peptides and proteins while the electron lucent parts of the organelles represent the storage site for histamine. 
DYNAMICS OF ECL CELL GRANULES AND VESICLES
Classification of organelles The cytoplasm of the ECL cells is rich in fairly large, electron-lucent vesicles, which have a small and eccentrically located dense core ( Figure 6 ). In addition, a few granules with prominent electron-dense core and a few clear microvesicles can be observed. In the case of long-term hypergastrinemia, the ECL cells display very large vesicles and electron dense bodies in their cytoplasm. We have classified the various organelles into granules, secretory vesicles, microvesicles, vacuoles and lipofuscin bodies ( Figure 7 ) [28, 29] . The granules are defined as cytoplasmic membrane-enclosed organelles (with a diameter of 25-200 nim), displaying an electron-dense core and a thin electron-lucent halo between the membrane and the dense core, the diameter of the dense core representing more than 50 percent of the diameter of the entire organelle. The vesicles are membrane-enclosed electronlucent organelles without a dense core or possessing a small, often eccentrically located dense core, the diameter of the dense core being less than 50 percent of the diameter of the organelle. Based on profile size, vesicles belong to one of three populations: 1) secretory vesicles with a diameter of 125-500 nm (with a dense core, which can be revealed by serial sectioning if not immediately apparent); 2) vacuoles with a diameter of at least 500 nm without visible dense core or possessing one (or more than one) dense core; and 3) electronlucent microvesicles with a diameter of 25-125 nm. Lipofuscin bodies are identified by their irregular shape and high electron density (osmiophilia).
We have proposed a model for the development and maturation of secretory organelles and for the mechanism behind the fusion of membranes in these cells [11, 30] . The granules with their content of chromogranin A and peptide hormone precursor bud off from the Golgi apparatus and start to take up histamine during their transport to the more peripheral parts of the cells. As a result, they turn into secretory vesicles, possibly through osmotic forces, generated by the progressive accumulation of histamine and other small molecules. Among small molecules that will accumulate in the secretory vesicles are cleavage products of chromogranin A (e.g., pancreastatin) and of the anticipated peptide hormone precursor, which are generated by proteolysis within the granules. According to this concept, we should expect the secretory vesicles to represent a readily releasable pool of histamine and other secretory products, while the granules should represent a less readily releasable pool. As a consequence of stimulation, the secretory vesicles fuse with the cell membrane to release their contents by exocytosis [11] . The microvesicles become numerous, perhaps as a result of stimulated recycling, which can be expected to lead to an increased number of retrieval vesicles [22] . Gastrin accelerates several of the steps that control the formation and subsequent maturation of the storage/secretory organelles, namely the formation of granules, their transformation into secretory vesicles, the excytosis and endocytosis (resulting in microvesicles), and the fusion of secretory vesicles with each other (resulting in vacuoles). Vacuoles and lysosomes probably play a role in the degradation of superfluous products (granule disposal or crinophagia). The highly electron dense material that accumulates within the lumen of lysosomes as a result of autophagic degradation is referred to as ceroid or lipofuscin (age pigment) [31] [32] [33] . We interpret the vacuoles and lipofuscin bodies that appear in ECL cells in response to long-term hypergastrinemia as crinophagic (autophagic) organelles. Development of granules into secretory vesicles a-Fluoromethylhistidine (a-FMH) is an irreversible and selective inhibitor of HDC [34] . Treatment with ax-FMH results in a loss of 65 to 90 percent of the histamine in the oxyntic mucosa of mouse, rat and hamster, and the number of secretory vesicles in the ECL cells is reduced in parallel ( Figure 8 ) [see also 13, 28, 35] . VMAT-2 has been found to exist in ECL cell granules/vesicles. Histamine is thought to accumulate in granules/secretory vesicles through action of VMAT-2. This transporter can be blocked by reserpine. Treatment with reserpine reduced greatly the number of large secretory vesicles while increasing the number of granules ( Figure 9 ). The combination of gastrin and reserpine still reduced the number of large secretory vesicles but increased greatly the number of granules ( Figure 10 ). Together, these findings support our hypotheses 1) that pre-formed histamine in the cytosol is taken up by granules, probably via VMAT-2 and 2) that the accumulation of histamine is necessary for transforming granules into secretory vesicles. Days of gastrin infusion 
Development of secretory vesicles into vacuoles
Vacuoles occur in response to long-term sustained hypergastrinemia induced by gastrin infusion or by treatment with gastric acid inhibitors such as omeprazole [22, 28, [36] [37] [38] . Their being engaged in fusion ( Figure 11 ). The following additional findings support the view that they result from the fusion of several secretory vesicles, namely 1) that the vacuoles at times contain more than one dense core ( Figure 12 ) and 2) that a-FMH or reserpine treatment prevented the formation of vacuoles, conceivably by preventing or impairing the formation of secretory vesicles ( Figure 13 ).
Development of vacuoles into lipofuscin
The increased number and volume density of vacuoles was associated with an increased number and volume density of lipofuscin bodies in the ECL cell cytoplasm in response to sustained gastrin stimulation (Figure 14 ). There was a good correlation between the number of vacuoles and of lipofuscin bodies (r = .965, p < .001) [29] . a-FMH-evoked ECL cell histamine depletion prevented the formation of vacuoles and also the development of lipofuscin ( Figure 15 ). These observations indicate that vacuoles contribute to the formation of which anchors them to the secretory vesicle membrane. CSP has so far only been shown to be associated with granules/secretory vesicles. SNAP-25 and syntaxin are associated with the plasma membrane, where syntaxin has a close relationship with calcium-channels. Munc-18 is located in the cytoplasm and has been shown to interact with syntaxin. Histamine is synthesized in the cytoplasm from histidine via the enzyme histidine decarboxylase (HDC), and is thereafter taken up via VMAT-2, located at the membrane of the granules/vesicles. lipofuscin. In ECL cells of hypergastrinemic rats, membrane-membrane fusion was seen not only between the secretory vesicles (resulting in vacuoles) but also between vacuoles and lipofuscin-containing secondary lysosomes ( Figure 16 ). The findings are in line with the view that vacuoles form part of the lysosomal compartment. In fact, it has been suggested previously that material within lysosomal membrane-bound vacuoles (secondary lysosomes) can aggregate or disperse through fusion and fission [32, 39] . SUMMARY 1. Exocytotic pathway. The granules bud off from the Golgi apparatus. The intragranular proteins condense in the process, forming an electron-dense core. The newly formed granules take up histamine from the cytosol by VMAT-2 during their transport from the Golgi area to the more peripheral parts of the cells. As a result, the granules turn into secretory vesicles. The secretory vesicles represent a readily releasable pool of secretory products. As a consequence of stimulation, the secretory vesicles fuse with the cell membrane to release their contents by exocytosis (Figure 17) . The ECL cells are rich in exocytotic proteins that promote granule/vesicle docking and fusion with the plasma membrane. Synaptophysin and VAMP-2 are vesicle proteins that participate in the docking of the organelle to the cell membrane. They bind to proteins in the cell membrane, such as SNAP-25 and syntaxin; cytosolic Munc-18 binds to syntaxin. The process of fusion of the secretory organelle with the cell membrane probably involves the interaction of synaptotagmin III, syntaxin and CSP with Ca2+ channels (Figure 18 ).
2. Crinophagic pathway. Long-lasting hypergastrinemia stimulates the development of vacuoles, which are formed by the fusion of several secretory vesicles. The development of vacuoles is associated with the development of lipofuscin bodies. The latter organelles probably result from lysosomal degradation of the vacuoles and their contents. The lipofuscin bodies contain the indigestible waste products of autophagia ( Figure 19 ). 
